Stockreport

Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial [Yahoo! Finance]

Pyxis Oncology, Inc.  (PYXS) 
PDF Tue, February 4, 2025 at 1:30 PM GMT+1 4 min read In This Article PYXS Pyxis Oncology - Initiation of Phase 1/2 combination trial with PYX-201, an extracellul [Read more]